Morcos Assaad A 4
4 · PREFORMED LINE PRODUCTS CO · Filed Aug 11, 2025
Insider Transaction Report
Form 4
Morcos Assaad A
VP, US Manufacturing
Transactions
- Exercise/Conversion
Common Shares, $2 par value per share
2025-08-04$61.24/sh+625$38,275→ 625 total - Exercise/Conversion
Employee stock option (right to buy)
2025-08-04$61.24/sh−625$38,275→ 0 totalExercise: $0.00→ Common Shares, $2 par value per share (625 underlying) - Disposition to Issuer
Common Shares, $2 par value per share
2025-08-04$154.28/sh−625$96,425→ 0 total
Holdings
- 681
Restricted stock units
Exercise: $0.00→ Common shares, $2 par value (681 underlying) - 7,500
Employee stock option (right to buy)
Exercise: $0.00→ Common Shares, $2 par value per share (7,500 underlying)
Footnotes (3)
- [F1]On July 19, 2022, the reporting person was granted 2,500 stock options, of which 1,250 vested on July 19, 2023, 625 vested on July 19, 2024, and the remaining 625 vested on July 19, 2025. This transaction refers to the exercise of the last vested tranche of 625 shares at the option strike price.
- [F2]Restricted stock units vest 3 years from the date of grant.
- [F3]On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 will vest on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.